ALK-Abelló

ALK-Abelló logo

ALK-Abelló A/S is a global pharmaceutical company specializing in the development and production of allergy immunotherapy products. The company is headquartered in Hørsholm, Denmark and operates in more than 30 countries worldwide. ALK-Abelló is a leader in the field of allergy immunotherapy, providing treatments for allergic conditions such as allergic rhinitis, allergic asthma, and anaphylaxis.

History

ALK-Abelló was founded in 1923 by Dr. Kaj Baagøe and Dr. Jørgen Lehmann. The company initially focused on the production of bacterial vaccines but later shifted its focus to allergy immunotherapy. Over the years, ALK-Abelló has expanded its product portfolio and geographical presence through strategic acquisitions and partnerships.

Products

ALK-Abelló offers a range of allergy immunotherapy products, including subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT). Some of the company's well-known products include:

• GRAZAX® - A tablet-based immunotherapy for grass pollen allergy.
• ACARIZAX® - A tablet-based immunotherapy for house dust mite allergy.
• RAGWITEK® - A tablet-based immunotherapy for ragweed pollen allergy.
• ALK-SQ® - A range of subcutaneous immunotherapy products for various allergens.

Research and Development

ALK-Abelló invests significantly in research and development to advance the field of allergy immunotherapy. The company's R&D efforts focus on improving the efficacy and safety of existing treatments, as well as developing new therapies for emerging allergens. ALK-Abelló collaborates with leading academic institutions and research organizations to drive innovation in allergy treatment.

Global Presence

ALK-Abelló operates in more than 30 countries, with a strong presence in Europe, North America, and Asia. The company has production facilities in Denmark, France, Spain, and the United States. ALK-Abelló's products are distributed through a network of subsidiaries, distributors, and partners worldwide.

Corporate Social Responsibility

ALK-Abelló is committed to corporate social responsibility (CSR) and sustainability. The company focuses on reducing its environmental impact, promoting ethical business practices, and supporting community initiatives. ALK-Abelló also engages in patient advocacy and education to raise awareness about allergic diseases and the benefits of immunotherapy.

See Also

• Allergy
• Immunotherapy
• Pharmaceutical industry
• Biotechnology
• Healthcare

External Links

• Official website

This article is a stub related to pharmacology. You can help WikiMD by expanding it!